Generic drug of the therapeutic class: Dermatology
active ingredients: Calcipotriol
Solution for scalp
Bottle of 120 ml
DAIVONEX Scalp Solution is indicated for the topical treatment of mild to moderate scalp psoriasis.
Dosage DAIVONEX 50 μg / ml Solution for scalp 120 ml bottle
- Adult: DAIVONEX solution for scalp should be applied twice daily (morning and evening) on the lesions. The maximum dose per week should not exceed 60 ml.
When used concomitantly with DAIVONEX Cream or DAIVONEX Ointment, the total dose of calcipotriol should not exceed 5 mg per week, eg 60 ml of DAIVONEX scalp solution plus a 30 g tube of cream or ointment, or 30 ml of DAIVONEX scalp solution plus 60 g (two 30 g tubes) of cream or ointment.
The duration of treatment will be indicated by the doctor but should not normally exceed 22 weeks.
- Child: Not recommended in the absence of experience of use in children.
- As with any topical, DAIVONEX Scalp Solution is contraindicated in patients with a history of allergy to the active substance or to any of the excipients.
- DAIVONEX Scalp Solution is contraindicated in patients with known calcium metabolism disorders and in patients with severe liver or kidney disease.
- DAIVONEX solution for scalp should not be applied directly to the face.
NOT RECOMMENDED :
- In the absence of experience in children, the use of DAIVONEX scalp solution is not recommended in children.
- Breast-feeding: The passage of calcipotriol into breast milk is not known.
Daivonex side effects
Very common> 1/10.
Frequent> 1/100 and <1/10.
Uncommon> 1/1000 and <1/100.
Rare> 1/10000 and <1/1000.
Very rare <1/10000.
About 25% of patients treated with DAIVONEX Scalp Solution may have an adverse effect. These reactions are usually benign.
- Immune system disorders:
Very rare : allergic reactions (including angioedema).
- Metabolic and nutritional disorders:
Very rare : hypercalcemia, hypercalciuria, especially if the recommended total dose is exceeded (see section titration and method of administration).
- Skin and subcutaneous tissue disorders:
. Very common : skin irritation.
. Common : skin rash *, burning sensation, tingling sensation, dryness of skin, pruritus, erythema, contact dermatitis (including facial and perioral).
. Uncommon : worsening of psoriasis, eczema.
. Unknown frequency : transient change in skin pigmentation, transient photosensitivity, urticaria, angioedema, periorbital edema, or facial.
* Different types of rash such as squamous, erythematous, maculopapular, pustular, bullous rash have been reported.